ACHIEVE LIFE SCIENCES, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Cash from operations | -$49.5M | -$29.8M | -$24.5M | -$37.6M | -$29.4M |
| Capital expenditure | $3,000 | — | $21,000 | — | — |
| Free cash flow | -$49.5M | — | -$24.5M | — | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $41.8M | $38.6M | $19.4M | $30.0M | $47.5M |
| Total liabilities | $20.3M | $17.7M | $20.8M | $21.7M | $19.5M |
Shares outstanding 102.7M · Free float 58.2%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.